CHSN: trading halted on Nasdaq — volatility pause (3:12 PM ET)
Nasdaq halted trading in CHSN (volatility pause) at 3:12 PM ET.
Related stories
ADMA Biologics Reports Third-Quarter 2026 Financial Results
ADMA reported third-quarter 2026 revenue of $141.1 million, up 5% year over year. The supplied update also lists ASCENIV revenue of $12, with no unit or further context provided.
M impact | EQUITY | Nov 04, 2026, 09:08 PM UTC
Vaxcyte Reports Q3 2026 Results, Positive VAX-31 Phase 3 Topline Data
Vaxcyte reported third-quarter 2026 financial results and announced positive topline data from the OPUS-1 pivotal Phase 3 trial for VAX-31’s adult indication.
M impact | EQUITY | Nov 04, 2026, 09:08 PM UTC
Dianthus Therapeutics reports Q3 revenue of $1.21M
M impact | EQUITY | Nov 04, 2026, 09:08 PM UTC
OnKure Therapeutics Reports Third-Quarter 2026 Financial Results
OnKure Therapeutics also announced PANORAMA, an OnKure-sponsored, large-scale, multiregional registry. The supplied body is truncated before describing its purpose.
M impact | EQUITY | Nov 04, 2026, 09:08 PM UTC
Magnolia Oil & Gas Reports Q3 Revenue of $513.9M
Q3 revenue was $513.9 million, versus a FactSet estimate of $474.4 million.
M impact | EQUITY | Nov 04, 2026, 09:08 PM UTC
Xperi Announces Third-Quarter 2026 Results
Xperi announced financial results for the quarter ended September 30, 2026.
M impact | EQUITY | Nov 04, 2026, 09:08 PM UTC